Ex-Senior Product Specialist (Life Sciences)
Dr Wang Tianhua obtained his PhD at Penn Center for Molecular Discovery, University of Pennsylvania (UPenn) in 2011 under the supervision of Prof Scott Diamond with a research focus on developing therapeutics for blocking SARS, Ebola virus infection.
He then worked in Analytics group at Bioprocessing Technology Institute (BTI), Agency for Science, Technology and Research Singapore (A*STAR). Over the 5 years at BTI, he served as the Co-PI and lead PI of two research grants (GlycoSing and HighGlycoArt) in establishing High throughput glyco-analytics platform based on Liquid Chromatography Mass Spectrometry (LCMS) for protein therapeutics development.
Dr Wang Joined Shimadzu Asia Pacific as a product specialist in 2017. He is taking care of the life science related products and applications in the South East Asia and South Asia region.
